John Paulson acquired 2.09M Madrigal Pharmaceuticals shares worth $901M. It makes up 31.71% of their stock portfolio and is their biggest holding. The investor owns 9.23% of the outstanding Madrigal Pharmaceuticals stock. John Paulson started to build up the position in Madrigal Pharmaceuticals in Q2 2023 and continued to invest until Q1 2025. Since then they sold 10k shares. The stake costed the investor $470M, netting the investor a gain of 92% so far.
Paulson & Co. exits Newmont stake, increases holdings in Horizon Therapeutics and Madrigal Pharma.
In this article, we discuss billionaire John Paulson¡¯s Messy divorce and top 5 stock picks. If you want to see more stocks in this selection, check out Billi...
Paulson & Co., the fund headed by John Paulson, added new stakes in Iveric Bio (ISEE) (25K shares), Madrigal Pharmaceuticals (MDGL) (350K shares), and Newmon...